| Zugriffe | |
|---|---|
| The pan‐JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase IIb trial | 9 |
| Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| The pan‐JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase IIb trial | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Zugriffe | |
|---|---|
| 2022_Worm_etal.pdf | 3 |
